BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus

Authors

Tobias Rothe (ORCID: https://orcid.org/0009-0008-4190-5005)
Michael Sticherling (ORCID: https://orcid.org/0000-0001-9396-3938)
Moritz Ronicke (ORCID: https://orcid.org/0000-0001-8828-0980)
Carola Berking (ORCID: https://orcid.org/0000-0003-0229-8931)
Ricardo Grieshaber-Bouyer
Georg Schett
Fabian Müller

Institutions

Friedrich-Alexander-Universität Erlangen-Nürnberg (DE)
Universitätsklinikum Erlangen (DE)

Publication Details

Journal: JAMA Dermatology
Published: 2026-09-30
DOI: https://doi.org/10.1001/jamadermatol.2026.3051
Primary Topic: Autoimmune Bullous Skin Diseases
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

article

BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus

Tobias Rothe, Michael Sticherling, Moritz Ronicke, Carola Berking et al.

Sep 30, 2026

JAMA Dermatology

Autoimmune Bullous Skin Diseases

article

BCMA-Targeted T-Cell Engager Therapy for Refractory Pemphigus

Tobias Rothe, Michael Sticherling, Moritz Ronicke, Carola Berking, Ricardo Grieshaber-Bouyer, Georg Schett, Fabian Müller

September 30, 2026article en

Abstract

No abstract available for this paper.

JAMA Dermatology

Friedrich-Alexander-Universität Erlangen-Nürnberg (DE), Universitätsklinikum Erlangen (DE)

Zero hunger

Openalex Percentile: Top 12%

Autoimmune Bullous Skin Diseases

DOI Source OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.